Prakash Deedwania

Active 1979–2025

108
Papers
26,983
Citations
80
h-index
103
i10-index

Citations

Citations per year for Prakash Deedwania1981: 1 citations1982: 3 citations1983: 3 citations1984: 2 citations1987: 4 citations1988: 1 citations1989: 2 citations1990: 7 citations1991: 11 citations1992: 12 citations1993: 11 citations1994: 12 citations1995: 20 citations1996: 31 citations1997: 41 citations1998: 67 citations1999: 94 citations2000: 92 citations2001: 113 citations2002: 103 citations2003: 119 citations2004: 147 citations2005: 161 citations2006: 170 citations2007: 171 citations2008: 179 citations2009: 190 citations2010: 176 citations2011: 195 citations2012: 163 citations2013: 157 citations2014: 145 citations2015: 143 citations2016: 154 citations2017: 159 citations2018: 160 citations2019: 478 citations2020: 469 citations2021: 460 citations2022: 345 citations2023: 343 citations2024: 510 citations2025: 230 citations2026: 19 citations1985–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,581 citing papers, 26.3% of this breakdownUnited Kingdom: 749 citing papers, 7.6% of this breakdownItaly: 538 citing papers, 5.5% of this breakdownChina: 509 citing papers, 5.2% of this breakdownGermany: 434 citing papers, 4.4% of this breakdownCanada: 426 citing papers, 4.3% of this breakdownAustralia: 348 citing papers, 3.6% of this breakdownNetherlands: 330 citing papers, 3.4% of this breakdownFrance: 315 citing papers, 3.2% of this breakdownSpain: 265 citing papers, 2.7% of this breakdownSweden: 250 citing papers, 2.6% of this breakdownIndia: 214 citing papers, 2.2% of this breakdown
0%26.3%Other 29%

Fields

  • Medicine86%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Nursing1.3%
  • Health Professions1.1%
  • Neuroscience1.1%
  • Computer Science0.7%
  • Other4.2%

Topics

  • Lipoproteins and Cardiovascular Health5.9%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.9%
  • Heart Failure Treatment and Management5.1%
  • Cardiovascular Function and Risk Factors4%
  • Diabetes Treatment and Management3.3%
  • Cardiac Imaging and Diagnostics3.1%
  • Other72.7%

Coauthors

All papers

Open in search
  1. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , - Circulation 2022 cited by 593

  2. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

    Authors: , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2017 cited by 596

  3. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , - Circulation 2020 cited by 295

  4. Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 203

  5. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , - Circulation 2023 cited by 123

  6. Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2000 cited by 1,394

  7. Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence A. Leiter, Naomi Levitt, Felipe Martinez, Felipe A. Martínez, Chantal Masson, Theodore Mazzone, Eduardo Meaney, Richard W. Nesto, Changyu Pan, Rudolf Prager, S. Raptis, Guy E.H.M. Rutten, Herbert Sandstroem, Frank Schäper, André Scheen, Ole Schmitz, Isaac Sinay, Vladimír Soška, Steen Stender, Gyula Tamás, Gianni Tognoni, Alberto S Villamil, Alberto S. Villamil, J Vozár - New England Journal of Medicine 2010 cited by 669

  8. Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association

    Authors: , , , , , , , , , , , - Circulation 2021 cited by 100

  9. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

    Authors: , , , , , , , , , , , , , , , , , , - Diabetes Care 2015 cited by 493

  10. Maintenance of Serum Potassium with Sodium Zirconium Cyclosilicate (ZS-9) in Heart Failure Patients: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , - European Journal of Heart Failure 2015 cited by 177

  11. Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

    Authors: , , , , , , , , , , , , , - Circulation 2008 cited by 472

  12. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , - JAMA Cardiology 2018 cited by 135

  13. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

    Authors: , , , , , , , , , - The Lancet 1997 cited by 1,669

  14. Identifying Heart Failure Patients at High Risk for Near-Term Cardiovascular Events With Serial Health Status Assessments

    Authors: , , , , , , - Circulation 2007 cited by 191

  15. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure

    Authors: , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 76

  16. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of clinical lipidology 2015 cited by 785

  17. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 220

  18. Therapeutic Inertia in Cardiovascular Disease Prevention

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 100

  19. Hyperglycemia and Acute Coronary Syndrome

    Authors: , , , , , , - Circulation 2008 cited by 495

  20. Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease

    Authors: , , , , - The American Journal of Medicine 2014 cited by 247

  21. Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy

    Authors: , , , , , , , , , , - JAMA Cardiology 2020 cited by 82

  22. Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

    Authors: , , , , , , , , - New England Journal of Medicine 1995 cited by 1,233

  23. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

    Authors: , , , , , , , , , , - Circulation 2008 cited by 884

  24. Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geetha Subramanyam, Debabatra Roy, Sibananda Datta, Kajal Ganguly, Satya Narayan Routray, Surabhi Mishra, Bhaskar Singh, Bhavneet Bharti, Mrinal Kanti Das, Soumitra Kumar, Kewal C. Goswami, Vinay K. Bahl, Sarat Chandra, Amal Kumar Banerjee, Santanu Guha, P.K. Deb, H K Chopra, Prakash Deedwania, Ashok Seth, J. Shivkumar Rao, Bhaskar Singh, Bhavneet Bharti, Amit Kumar Sinha, Kartik Gupta, Sivasubramanian Ramakrishnan, Sudha Bhushan, Sunil Kumar Verma, Balram Bhargava, Ambuj Roy, Sandeep Bansal, Sanjay Sood, H.S. Isser, Neeraj Pandit, Ranjit Kumar Nath, Sanjay Tyagi, Vijay Trehan, Mohit Gupta, M.P. Girish, Ramandeep Ahuja, S.C. Manchanda, A. K. Mohanty, Peeyush Jain, Sameer Shrivastava, Ish Kalra, Bhakti Sarang, H.S. Ratti, G. Bala Sahib, Rakesh Gupta, S. K. Agarwal, Amit, Kewal C. Goswami, Vinay K. Bahl, H K Chopra, Ashok Seth, Geevar Zachariah, Padhinhare P. Mohanan, K. Venugopal, George Koshy, Tiny Nair, N. D. V. N. Shyam, Anil Roby, Raju George, Sudhaya Kumar, Md Abdul Kader, Mathew Abraham, Sunitha Viswanathan, A. Jabir, Jaideep Menon, Govindan Unni, Cibu Mathew and 44 more - Indian Heart Journal 2019 cited by 210